ArticleLipids in health and disease2022

Evaluating the use of novel atherogenicity indices and insulin resistance surrogate markers in predicting the risk of coronary artery disease: a case‒control investigation with comparison to traditional biomarkers.

Marjan Mahdavi-Roshan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.